Bridgeway Capital Management’s Anterix ATEX Stock Holding History
Bought
Maintained
Sold
Other funds holding ATEX
OCAM
LCM
FS
AFG
SSP
BCC
Bridgeway Capital Management's ATEX Position: Q1 2020 in Review
Bridgeway Capital Management sold out of Anterix (ATEX) in Q1 2020, closing a stake of 12,100 shares — an estimated $523K sold.
Bridgeway Capital Management first reported a position in ATEX in Q3 2019 and held it in 2 quarters. The position peaked at $523K in Q4 2019. 84 funds tracked by Wall St. Rank hold ATEX as of Q1 2020.
- Bridgeway Capital Management reported no remaining Anterix position as of Q1 2020 after selling out during the quarter.
- Bridgeway Capital Management sold 12,100 Anterix shares in Q1 2020, an estimated $523K.
- Bridgeway Capital Management first reported a position in Anterix in Q3 2019 and held it in 2 quarters.
- Bridgeway Capital Management's Anterix position peaked at $523K in Q4 2019.
- 84 funds tracked by Wall St. Rank held Anterix as of Q1 2020.
Based on Bridgeway Capital Management's 13F filing for Q1 2020, filed 15 May 2020.